Biopharmaceutical research and development saves American lives. Intellectual property waivers stifle American ingenuity and our freedom to create lifesaving medicines. We need to strengthen this country’s biomedical research and manufacturing sectors – not weaken them.

Tell Washington not to extend the TRIPS waiver so we can protect American innovation, jobs, and intellectual property rights.

Read More Here

PILMA partners are working around the clock to assist in a time of exponential need:

• Rapidly screening vast global libraries of medicines to identify potential treatments and ramp up numerous clinical trials to test new and existing therapies.
• Helping to respond to the sick in communities across the country while putting their own health and families at risk.
• Diverting existing resources to speed the development of safe and effective vaccines and treatments.
• Playing a critical role to ensure that workers displaced and laid off because of economic uncertainty and COVID-19 get the assistance they need.
• Expanding manufacturing capabilities to ramp up production once a medicine or vaccine is developed.
• Collaborating with government agencies, hospitals, doctors and others to donate supplies and medicines to those affected in the U.S. and around the world.  North America’s Building Trades are donating N-95 masks and other equipment to nurses on the frontlines. 
• Working with governments and insurers so that when new treatments and vaccines are approved they will be available, accessible, and affordable for all patients.